Day One Biopharmaceuticals Inc (DAWN)
17.17
-0.40
(-2.28%)
USD |
NASDAQ |
May 03, 16:00
17.15
-0.02
(-0.12%)
After-Hours: 20:00
Day One Biopharmaceuticals Cash from Operations (TTM): -146.85M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -146.85M |
| September 30, 2023 | -140.79M |
| June 30, 2023 | -126.94M |
| March 31, 2023 | -114.30M |
| December 31, 2022 | -109.87M |
| September 30, 2022 | -87.73M |
| June 30, 2022 | -76.74M |
| Date | Value |
|---|---|
| March 31, 2022 | -60.36M |
| December 31, 2021 | -48.54M |
| September 30, 2021 | -41.31M |
| June 30, 2021 | -32.66M |
| March 31, 2021 | -21.15M |
| December 31, 2020 | -13.49M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-146.85M
Minimum
Dec 2023
-13.49M
Maximum
Dec 2020
-78.52M
Average
-76.74M
Median
Jun 2022
Cash from Operations (TTM) Benchmarks
| Revolution Medicines Inc | -350.57M |
| Zentalis Pharmaceuticals Inc | -207.82M |
| Perspective Therapeutics Inc | -36.91M |
| Electromed Inc | 4.872M |
| Xtant Medical Holdings Inc | -9.515M |